Fetal cfDNA testing can determine if a fetus lacks an antigen that could cause HDFN, avoiding further unnecessary tests and ...
Immune response successfully improved with second generation vaccine candidateSaint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: ...
This study aimed to generate yak-specific polyclonal antibodies against transforming growth factor beta 2 (TGF-β2). Specific primers targeting the TGF-β2 coding sequence (CDS) were designed, and the ...
An old wives’ tale claims male pattern baldness comes from the maternal side of the family tree. But if your mother’s father’s full head of hair has given you hope that your own mop will remain intact ...
GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates, but the Big Pharma’s oncology R&D chief told Fierce to “stay tuned” for the company’s own data. The ...
REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (BMY) today announced the oral ...
The authors investigated the potential role of IgG N-glycosylation in Haemorrhagic Fever with Renal Syndrome (HFRS), which may offer significant insights for understanding molecular mechanisms and for ...
This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...
In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback